SCHEMBL2507290

SCHEMBL2507290

CCCCN1Cc2cc(NCc3cnccc3Nc3ccccc3)ccc2C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.39
GRM5 P41594 2/20 0.38
KDM4C Q9H3R0 3/20 0.38
IDH1 O75874 1/20 0.37
CRBN Q96SW2 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
APP P05067 1/20 0.35
CCNB2 O95067 1/20 0.34
CCNE2 O96020 1/20 0.34
CDK1 P06493 1/20 0.34
FGFR1 P11362 1/20 0.34
CDK4 P11802 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR4 P22455 1/20 0.34
FGFR3 P22607 1/20 0.34
CCND1 P24385 1/20 0.34
CCNE1 P24864 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2509716 0.90 KDM4E (0.38) HDAC6GRM5KDM4CIDH1CRBN
SCHEMBL2514240 0.87 IDH1 (0.40) HDAC6GRM5KDM4CIDH1CRBN
SCHEMBL2511394 0.84 KDM4C (0.38) HDAC6GRM5KDM4CIDH1CRBN
SCHEMBL2511385 0.84 HDAC6 (0.38) HDAC6GRM5IDH1CRBNALDH1A1
SCHEMBL2511620 0.84 CRBN (0.37) HDAC6CRBNPRF1
SCHEMBL2511637 0.83 AAK1 (0.38) HDAC6KDM4CCRBNALDH1A1MAPK1
SCHEMBL2503427 0.81 HDAC6 (0.43) HDAC6GRM5KDM4CIDH1ALDH1A1
SCHEMBL2510813 0.81 BRD9 (0.40) HDAC6GRM5CRBNPRF1GAA
SCHEMBL2515759 0.80 MAPT (0.45) HDAC6ALDH1A1MAPK1GAAKDM4E
SCHEMBL2512032 0.80 GPBAR1 (0.38) HDAC6GRM5CRBNGRM1PRF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664214-B2 Small molecule potentiators of metabotropic glutamate receptors I AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-04 US claimed
US-8664214-B2 Small molecule potentiators of metabotropic glutamate receptors I AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-04 US disclosed
US-20110245232-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I ABBOTT GMBH & CO. KG (DE) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245232-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I GRM3, GRIN2C, GRIN2B HDAC6 2366/4885GRM5 17/4885KDM4C 2588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.